234 related articles for article (PubMed ID: 36929190)
1. Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering.
Hu S; Fei M; Fu B; Yu M; Yuan P; Tang B; Yang H; Sun D
Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2277-2288. PubMed ID: 36929190
[TBL] [Abstract][Full Text] [Related]
2. Rerouting Fluxes of the Central Carbon Metabolism and Relieving Mechanism-Based Inactivation of l-Aspartate-α-decarboxylase for Fermentative Production of β-Alanine in
Li B; Zhang B; Wang P; Cai X; Chen YY; Yang YF; Liu ZQ; Zheng YG
ACS Synth Biol; 2022 May; 11(5):1908-1918. PubMed ID: 35476404
[TBL] [Abstract][Full Text] [Related]
3. Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis.
Hu S; Zhao L; Hu L; Xi X; Zhang Y; Wang Y; Chen J; Chen J; Kang Z
Enzyme Microb Technol; 2022 Aug; 158():110038. PubMed ID: 35453037
[TBL] [Abstract][Full Text] [Related]
4. Pathway construction and metabolic engineering for fermentative production of β-alanine in Escherichia coli.
Zou X; Guo L; Huang L; Li M; Zhang S; Yang A; Zhang Y; Zhu L; Zhang H; Zhang J; Feng Z
Appl Microbiol Biotechnol; 2020 Mar; 104(6):2545-2559. PubMed ID: 31989219
[TBL] [Abstract][Full Text] [Related]
5. Efficient Fermentative Production of β-Alanine from Glucose through Multidimensional Engineering of
Zhang Y; Zhang G; Zhang H; Tian Y; Li J; Yun J; Zabed HM; Qi X
J Agric Food Chem; 2024 Jun; 72(25):14274-14283. PubMed ID: 38867465
[TBL] [Abstract][Full Text] [Related]
6. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
[TBL] [Abstract][Full Text] [Related]
7. Metabolic engineering of Escherichia coli for production of L-aspartate and its derivative β-alanine with high stoichiometric yield.
Piao X; Wang L; Lin B; Chen H; Liu W; Tao Y
Metab Eng; 2019 Jul; 54():244-254. PubMed ID: 31063790
[TBL] [Abstract][Full Text] [Related]
8. Enhancing β-alanine production from glucose in genetically modified Corynebacterium glutamicum by metabolic pathway engineering.
Wang JY; Rao ZM; Xu JZ; Zhang WG
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9153-9166. PubMed ID: 34837493
[TBL] [Abstract][Full Text] [Related]
9. Systems metabolic engineering of Corynebacterium glutamicum for the efficient production of β-alanine.
Ghiffary MR; Prabowo CPS; Adidjaja JJ; Lee SY; Kim HU
Metab Eng; 2022 Nov; 74():121-129. PubMed ID: 36341775
[TBL] [Abstract][Full Text] [Related]
10. Multiplex modification of Escherichia coli for enhanced β-alanine biosynthesis through metabolic engineering.
Wang P; Zhou HY; Li B; Ding WQ; Liu ZQ; Zheng YG
Bioresour Technol; 2021 Dec; 342():126050. PubMed ID: 34597803
[TBL] [Abstract][Full Text] [Related]
11. High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917.
van 't Hof M; Mohite OS; Monk JM; Weber T; Palsson BO; Sommer MOA
BMC Bioinformatics; 2022 Dec; 23(1):566. PubMed ID: 36585633
[TBL] [Abstract][Full Text] [Related]
12. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
[TBL] [Abstract][Full Text] [Related]
13. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
[TBL] [Abstract][Full Text] [Related]
14. Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering.
Dong MM; Song L; Xu JQ; Zhu L; Xiong LB; Wei DZ; Wang FQ
Appl Microbiol Biotechnol; 2023 Aug; 107(16):5257-5267. PubMed ID: 37405431
[TBL] [Abstract][Full Text] [Related]
15. A Novel Biosynthetic Pathway for the Production of Acrylic Acid through β-Alanine Route in
Ko YS; Kim JW; Chae TU; Song CW; Lee SY
ACS Synth Biol; 2020 May; 9(5):1150-1159. PubMed ID: 32243749
[TBL] [Abstract][Full Text] [Related]
16. Prospective and challenges of live bacterial therapeutics from a superhero
Effendi SSW; Ng IS
Crit Rev Microbiol; 2023 Sep; 49(5):611-627. PubMed ID: 35947523
[No Abstract] [Full Text] [Related]
17. Metabolic engineering of E. coli for β-alanine production using a multi-biosensor enabled approach.
Yuan SF; Nair PH; Borbon D; Coleman SM; Fan PH; Lin WL; Alper HS
Metab Eng; 2022 Nov; 74():24-35. PubMed ID: 36067877
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
Raghuvanshi R; Chaudhari A; Kumar GN
Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
[TBL] [Abstract][Full Text] [Related]
19. Systems engineering of Escherichia coli for high-level shikimate production.
Li Z; Gao C; Ye C; Guo L; Liu J; Chen X; Song W; Wu J; Liu L
Metab Eng; 2023 Jan; 75():1-11. PubMed ID: 36328295
[TBL] [Abstract][Full Text] [Related]
20. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Fiege K; Frankenberg-Dinkel N
Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
